TrialAmerican journal of physiology. Regulatory, integrative and comparative physiology2011

Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants.

Lacy A Holowatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.